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Populations of the food- and waterborne pathogen Escherichia coli O157:H7 are comprised of two major
lineages. Recent studies have shown that specific genotypes within these lineages differ substantially in the
frequencies with which they are associated with human clinical disease. While the nucleotide sequences of the
genomes of lineage I strains E. coli O157 Sakai and EDL9333 have been determined, much less is known about
the genomes of lineage II strains. In this study, suppression subtractive hybridization (SSH) was used to
identify genomic features that define lineage II populations. Three SSH experiments were performed, yielding
1,085 genomic fragments consisting of 811 contigs. Bacteriophage sequences were identified in 11.3% of the
contigs, 9% showed insertions and 2.3% deletions with respect to E. coliO157:H7 Sakai, and 23.2% did not have
significant identity to annotated sequences in GenBank. In order to test for the presence of these novel loci in
lineage I and II strains, 27 PCR primer sets were designed based on sequences from these contigs. All but two
of these PCR targets were found in the majority (51.9% to 100%) of 27 lineage II strains but in no more than
one (<6%) of the 17 lineage I strains. Several of these linage II-related fragments contain insertions/deletions
that may play an important role in virulence. These lineage II-related loci were also shown to be useful markers
for genotyping of E. coli O157:H7 strains isolated from human and animal sources.
Enterohemorrhagic Escherichia coli is associated with diar-
rhea, hemorrhagic colitis, and hemolytic-uremic syndrome in
humans (31). E. coli serotype O157:H7 predominates in epi-
demics and sporadic cases of enterohemorrhagic E. coli-re-
lated infections in the United States, Canada, Japan, and the
United Kingdom (12). Cattle are considered the most impor-
tant reservoir of E. coli O157:H7 (10, 24, 37, 41), and foods
contaminated with bovine feces are thought to be the most
common source of human infection with this pathogen (27,
33). The two most important virulence factors of the organism
are the production of one or more Shiga toxins (Stx) (6, 20, 32)
and the ability to attach to and efface microvilli of host intes-
tinal cells (AE). Stx genes are encoded by temperate bacterio-
phage inserted in the bacterial chromosome, and genes respon-
sible for the AE phenotype are located on the locus of
enterocyte effacement (LEE) as well as other pathogenicity
islands (4, 17). All E. coli O157:H7 strains also possess a large
plasmid which is thought to play a role in virulence (10, 40, 42).
Octamer-based genome scanning (OBGS) was first used to
show that E. coli O157 strains from the United States and
Australia could be subdivided into two genetically distinct lin-
eages (21, 22, 46). While both E. coli O157:H7 lineages are
associated with human disease and are isolated from cattle,
there is a bias in the host distribution between the two lineages,
with a significantly higher proportion of lineage I strains iso-
lated from humans than lineage II strains. Several recent stud-
ies have shown that there are inherent differences in gene
content and expression between populations of lineage I and
lineage II E. coli O157:H7 strains. Lejeune et al. (26) reported
that the antiterminator Q gene of the stx2-converting bacterio-
phage 933W was found in all nine OBGS lineage I strains
examined but in only two of seven lineage II strains, suggesting
that there may be lineage-specific differences in toxin produc-
tion. Dowd and Ishizaki (9) used DNA microarray analysis to
examine expression of 610 E. coli O157:H7 genes and showed
that lineage I and lineage II E. coli O157:H7 strains have
evolved distinct patterns of gene expression which may alter
their virulence and their ability to survive in different micro-
environments and colonize the intestines of different hosts (9,
28, 38).
The observations of lineage host bias have been supported
and extended by studies using a six-locus-based multiplex PCR
termed the lineage-specific polymorphism assay (LSPA-6)
(46). However, Ziebell et al. (48) have recently shown that not
all LSPA-6 types within lineage II are host biased; e.g., LSPA-6
type 211111 isolation rates from humans and cattle were sig-
nificantly different from those of other lineage II LSPA-6
types. Therefore, a clearer definition is required of not only the
differences between lineages but also the differences among
clonal groups within lineages.
The genome sequences of two E. coli O157:H7 strains, Sakai
and EDL933 (14, 36), have been determined; however, both of
these strains are of lineage I, and there are presently no com-
pleted and fully annotated genome sequences available for
lineage II strains. In our laboratory, comparative studies uti-
lizing suppression subtractive hybridization (SSH) and com-
parative genomic hybridization revealed numerous potential
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virulence factors that are conserved in lineage I strains and
that are rare or absent in lineage II strains (42, 47). In this
study, we have used SSH to identify genomic regions present in
E. coli O157:H7 lineage II strains that are absent from lineage
I strains. We wished to examine the distribution of these novel
gene segments in E. coli O157:H7 strains and gain insight into
their origins and functions. We also attempted to identify mo-
lecular markers specific to lineage II strains as well as other
markers that would be useful in the genetic subtyping or mo-
lecular fingerprinting of E. coli O157:H7 strains in population
and epidemiological studies (25). This information may be
helpful in the identification of genotypes of the organism as-
sociated with specific phenotypes of both lesser and greater
virulence (29).
MATERIALS AND METHODS
Bacterial strains. OBGS type strains (93-001, FDA 516-520, and FRIK 523-
2001) were previously described by Kim et al. (21). Zap strains were obtained
from David Gally at the University of Edinburgh (30). Escherichia coli O157:H7
strains EDL933 (ATCC 700927) and Sakai (RIMD 0509952) were obtained from
the American Type Culture Collection (Manassas, VA). The remaining strains
were isolated from human infections or cattle in Canada (Table 1). LSPA-6
genotyping of these strains was performed as previously described (48).
Preparation of the SSH DNA library. Bacterial cultures were grown overnight
in brain heart infusion broth (Difco, Becton, Dickinson and Company, Franklin
Lakes, NJ) in a 37°C shaker-incubator (200 rpm) and genomic DNA was ex-
tracted from harvested cells using the DNeasy tissue kit (Qiagen, Valencia, CA).
The purity and concentration of the genomic DNA were assessed using a Nano-
drop ND-1000 spectrophotometer (Nanodrop Technologies, Rockland, DE).
SSHs were performed using the Clontech PCR-Select bacterial genome sub-
traction kit (BD Biosciences, Palo Alto, CA). In addition to the RsaI-digested
DNA recommended in the Clontech kit, SSHs were also performed on AluI- and
HaeIII-digested DNA to increase the diversity of DNA fragments obtained.
Advantage polymerase mix (BD Biosciences) was used during the amplification
steps. Three sets of SSH experiments were performed. In the first set, E. coli
FRIK 920 (LSPA-6 222222) was subtracted with E. coli Sakai (LSPA-6 111111).
In the second set, E. coli FRIK 1999 (LSPA-6 222222) was subtracted with E. coli
Sakai. In the third set, E. coli FRIK 2001 (LSPA-6 212232) was subtracted with
E. coli 93-001 (LSPA-6 111111).
The SSH DNA fragments isolated in these experiments were cloned into the
pCR2.1-TOPO plasmid vector, using the TOPO TA cloning kit (Invitrogen,
Carlsbad, CA) and plated onto LB agar (Difco) containing 50 g/ml of ampicillin
or kanamycin (Sigma-Aldrich Canada, Oakville, ON, Canada). Prior to cloning,
the fragments were incubated for 10 min at 72°C in the presence of AmpliTaq
DNA polymerase (Applied Biosystems, Foster City, CA) to ensure that all DNA
fragments possessed the necessary “A” overhang.
DNA sequencing of SSH DNA library. PCR amplicons were generated directly
from the SSH library clones by transferring whole bacterial cells to 20-l aliquots
of PCR master mix containing 1 buffer II (Applied Biosystems), 1.5 mM
MgCl2, 0.2 mM each deoxynucleoside triphosphates, 1 U AmpliTaq DNA poly-
merase (Applied Biosystems), and 0.2 M each M13 Forward (5-GTAAAAC
GACGGCCAG-3) and M13 Reverse (5-CAGGAAACAGCTATGAC-3)
PCR primer sets (Invitrogen). An initial 10-min incubation at 94°C performed to
lyse the cells was followed by 30 cycles of 1 min at 94°C, 1 min at 55°C, and 1 min
at 72°C and a final 10-min extension step at 72°C. PCR amplicons were purified
by passage through superfine Sephadex G-50 (Sigma) packed into a MultiScreen
96-well filtration plate (Millipore, Billerica, MA) and sequenced with the
DYEnamic ET terminator cycle sequencing kit (GE Health Care, Piscataway,
NJ) using M13 Forward and M13 Reverse primer sets. Sequencing products were
purified by passage through superfine Sephadex G-50 packed into a MultiScreen
96-well filtration plate prior to nucleotide sequencing on a MegaBace 500 cap-
illary sequencer (GE Health Care).
DNA sequence analysis of the SSH DNA library. Phred base calling of se-
quence trace data was performed using the Interphace program (CodonCode
Corporation, Dedham, MA). Base-called sequences obtained from each set of
SSH experiments were analyzed by the SeqMan 5.05 sequence analysis program
(DNAStar Inc., Madison, WI). This program removed vector and adaptor se-
quences and grouped sequences displaying at least 80% sequence homology into
contiguous consensus sequences or “contigs.” Searches were performed on con-
tigs using BLASTN and BLASTX (2) from the National Center for Biotechnol-
ogy Information (NCBI; http://www.ncbi.nlm.nih.gov/).
PCR screening of putative lineage II conserved markers. Twenty-seven PCR
primer sets were designed to detect frequently occurring sequences within the
SSH libraries. These primer sets were used to screen 17 E. coli O157:H7 LSPA-6
111111 strains, 17 genotype 222222 strains, five genotype 211111 strains, and five
strains of other genotypes (Table 1). Primer Select 5.08 (DNAStar Inc.) was used
to design PCR primer sets (Table 2). All PCR assays were performed in dupli-
cate in 20-l reaction mixture volumes containing 1 buffer II (Applied Biosys-
tems), 1.5 mM MgCl2, 0.2 mM deoxynucleoside triphosphates, 1 U AmpliTaq
DNA polymerase (Applied Biosystems), 0.2 M primer sets, and 0.5 ng genomic
DNA template. All PCRs included an initial 2-min denaturation step at 94°C,
followed by 30 cycles of 1 min denaturation at 94°C, 1 min annealing, and 1 min
extension at 72°C, and a final 10-min extension at 72°C. The primer sequences
and annealing temperatures for each PCR are listed in Table 2. Positive PCR
controls included the SSH tester E. coli strains FRIK 920, FRIK 1999, and FRIK
2001 and negative controls included Campylobacter jejuni ATCC 33560 and a
no-template blank. E. coli FRIK 920 amplicons obtained from all primer sets
were purified using the QIAquick PCR purification kit (Qiagen) and sequenced
TABLE 1. Escherichia coli O157:H7 strains included in
the study (n  44)
Strain LSPA-6genotype Source
Country of
origina
Phage
type
ECI1375 111111 Bovine Canada 14
ECI1382 111111 Bovine Canada 1
ECI563 111111 Bovine Canada 14
ECI577 111111 Bovine Canada 4
ECI603 111111 Bovine Canada 87
ECI653 111111 Bovine Canada 32
ECI665 111111 Bovine Canada 1
93001 111111 Human U.S.A. 14
ECI309 111111 Human Canada 14
ECI320 111111 Human Canada 14
ECI485 111111 Human Canada 14
EDL933 111111 Human U.S.A. 21
FDA 516 111111 Human U.S.A. 21
FDA 518 111111 Human U.S.A. 21
FDA 520 111111 Human U.S.A. 1
FRIK 523 111111 Human U.S.A. 34
Sakai 111111 Human Japan 32
Zap0032 211111 Bovine Scotland 8
Zap0054 211111 Bovine Scotland 32
ECI504 211111 Human Canada 2
ECI882 211111 Human Canada 1
Zap0058 211111 Human Scotland 87
ECI241 212222 Human Canada 74
FRIK 2001 212232 Bovine U.S.A. 54
ECI240 212232 Human Canada 54
EC19930200 222221 Bovine Canada 23
FRIK 1985 222232 Bovine U.S.A. 45
EC19920005 222222 Bovine Canada 67
EC19920027 222222 Bovine Canada 34
EC19920171 222222 Bovine Canada 23
EC19970520 222222 Bovine Canada 67
EC20011139 222222 Bovine Canada 82
EC20030223 222222 Bovine Canada 74
EC20030289 222222 Bovine Canada 23
ECI1433 222222 Bovine Canada 23
ECI564 222222 Bovine Canada 23
ECI633 222222 Bovine Canada 23
FRIK 1990 222222 Bovine U.S.A. 54
FRIK 1999 222222 Bovine U.S.A. 23
FRIK 920 222222 Bovine U.S.A. 23
ECI306 222222 Human Canada 23
ER6554 222222 Human Canada 23
ER6666 222222 Human Canada 40
ER6816 222222 Human Canada 40
a U.S.A., United States.
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on an ABI Prism 277 DNA sequencer (Applied Biosystems, Foster City, CA)
to verify that they corresponded to the sequences from the original contig
assembly.
Analysis of distribution of lineage II conserved regions in E. coli O157:H7
strains. Results of PCR screening assays targeting lineage II conserved markers
within the 44 strains tested were converted into presence/absence binary data. A
neighbor-joining dendrogram was generated based on a matrix of pairwise dis-
tances calculated from the binary data, using the proportion of shared markers
as a distance metric. Based on similar BLASTN homologies and strain distribu-
tions, some PCR primer sets appeared to recognize the same locus. To avoid
biasing the dendrogram results, a single representative PCR assay from each of
these 18 loci was included in the final binary data. The data were subsequently
bootstrapped, and a neighbor-joining consensus dendrogram was created using
the neighbor and consense programs from Phylip v3.16 (11). E. coli K-12 (5) was
used as an out-group strain in the dendrogram since in silico analysis indicated
that none of the primer sets would have generated a PCR product of the correct
size in this strain.
RESULTS AND DISCUSSION
SSH DNA library sequences. The three lineage II-minus-
lineage I SSH libraries yielded 811 contigs, which were ob-
tained from 1,085 clones. Each contig represented between 1
and 27 of the clones obtained, with an average of 1.58  1.90
clones per contig (Table 3). Sequence identities of the contigs
were obtained from BLASTN searches, and sequences were
binned into six different classes (A to F), based on sequence
TABLE 2. Primer sets used in PCR screening of lineage II conserved markers among E. coli O157:H7 strains
Class Primer set Forward primer Reverse primer Temp (°C)
B A02 5-GCTGGCAGACAATGGCGAGTTT-3 5-GATACGGCTTGCGGGCTGTG-3 59.3
A03 5-GCCACGGCATTAATAACGCTTCTT-3 5-CCAGGCATCACTACCCGCAAAAA-3 57.4
A04 5-GGAGACGGGCGCACTGATTG-3 5-CTCCACGATTTCGGGGCTTATGTA-3 56.2
A05 5-TGCGGCATCTGGTCATTCTGGTT-3 5-ACGGTCTGCGCGAGTTTTGTTT-3 57.3
A09 5-AGGGGGCATATTTCATTGTTGTGT-3 5-TAATCTCTTTCGCCTGCCCTTCTT-3 56.4
A10 5-CGAGGCGTGCGGAGAGGA-3 5-TTCAGCGCCAGTTCGGTTTTC-3 58.8
A11 5-AAAACCGTATGATCTATTATTCCT-3 5-TTTTTATTATGTTGGCTGAGTTAC-3 50.3
A13 5-ATGCCAGCCACCACCAACTCCAC-3 5-CTTACCCGCGCCGAACTTATCCTT-3 58.2
B01 5-AAGCCCCCACGTAATTCCCTGACA-3 5-CATTTCCCGCGCCTGACTGAGA-3 60.7
B02 5-AAGCGGCATAAATGGCAGACAGAC-3 5-AACGCCACGCTTTACCTTTACCC-3 57.8
B03 5-AATCCGCCCGTTTTTACTGA-3 5-TGTGCCTGATAGCTCCTTCTTTTT-3 54.9
B06 5-CCCCCTGTTGCGTCTGCTGAAAA-3 5-CGGCCATCCATGCGGTGACTT-3 60.8
B07 5-TAAAGCGCTGGTGGGGAAAGGTAG-3 5-CCAGAACGCGGGCACAAAAA-3 54.5
B08 5-TGCCGACATCGCCAGTTG-3 5-GCCATGCTTCAGGGAGATAAAT-3 55.7
B10 5-TGTGCGTCGTTTCAGTTCGTCA-3 5-TAGGTGTTCCGCGTCGTGTAAAAG-3 57.8
B16 5-CATGCTTCTGCCCTGAGTT-3 5-GCGCCGTGCTTATGAAA-3 54.8
C A14 5-TGCCGACAACCTCCCACAGATACT-3 5-TCACTTCCGCTACAACACGCACAT-3 57.8
A15 5-CGCCAAAGCAGCACAGCAGGATA-3 5-AGAAAAACAGGCGAAGGCGATGAT-3 53.4
D A06c 5-CCGCCTGCGATGGTGGTTGC-3 5-GGGCGCGGGTGATTTTGCTCTC-3 60.2
A07 5-ATGCGATCGCCTTCTTCAA-3 5-TACCATACACGCCACAGTTTTTA-3 52.3
B15 5-CCCGCTGGCAGGCATTGAAG-3 5-GGCGGCAGCGGACACGAG-3 60.4
E A01 5-ACCAAGGCATCCCCCGTGTGAA-3 5-ATAATCCGCTGGGGCTGGCTGAC-3 60.8
B05 5-GGTTTTCCGGCACTTTCCACTCCA-3 5-ATCCTGCCGGGCGAACATCCTTAT-3 58.1
B12 5-TGAACACCCGCAGCAACA-3 5-CGCCGCATCTACTCCTATCG-3 54.2
B18 5-AATAACTCGGCTTTTGCTTTTT-3 5-AATACTCCGGTTCTGTCTAATCC-3 52.5
F A12 5-GGGCGGACTTTGTTTGGTTGAA-3 5-GCCTGGCGGAAATGGACTGTAT-3 55.9
B13 5-CTGGATGCGGCAAAACCTGT-3 5-GCCCCTTCTCTACGCAAATCAT-3 55.0
TABLE 3. Frequency of sequence classes within SSH DNA libraries
Sequence
classa
No. (%) of clones present in:
Range Avg no. ofclones/contigAll contigs (n  811) 3 SSH (n  16) 2 SSH (n  73) 1 SSH (n  722)
A 503 (62.0) 5 (31.3) 30 (41.1) 468 (64.7) 1–7 1.30  0.82
B 92 (11.3) 10 (66.7) 34 (46.6) 48 (6.6) 1–16 2.90  2.64
C 72 (8.9) 3 (18.8) 12 (16.4) 57 (7.9) 1–7 1.60  1.22
D 19 (2.3) 0 (0) 6 (8.2) 13 (1.8) 1–5 1.79  1.13
E 80 (9.9) 1 (13.3) 8 (12.7) 72 (9.7) 1–27 3.01  4.67
F 188 (23.3) 5 (31.3) 14 (19.2) 177 (24.5) 1–11 1.67  1.65
All 1–27 1.58  1.90
a Class A, sequences with homology to E. coli Sakai (14) genes; class B, sequences with homology to bacteriophage sequences not found in E. coli Sakai; class C,
putative mosaic sequences with homology to both E. coli Sakai and non-Sakai DNA sequences within the same contig; class D, sequences with homology to E. coli Sakai
genes but lacking synteny with the E. coli Sakai chromosome; class E, sequences with homology to previously published nonbacteriophage and non-Sakai DNA
sequences; class F, sequences with regions containing no homology to any annotated DNA sequences in GenBank.
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identity to E. coli O157:H7 strain Sakai (A), non-Sakai bacte-
riophage (B), transitional sequences between lineage-common
and lineage II strain-specific DNA (C), sequence deletions in
the E. coli O157:H7 lineage II strain with respect to strain
Sakai (D), nonbacteriophage DNA found in bacteria other
than O157 strain Sakai (E), and those bearing little or no
sequence identity to sequences in the GenBank NR database
(F). Because many contigs contained sequences that could be
ascribed to more than one class, the relative proportions of the
different classes exceed 100%.
Class A contigs possessed at least 90% identity over at least
90% of their length to sequences from E. coli Sakai (14) and
likely represent driver DNA contamination or lineage II se-
quences with only minor deviations from that in the lineage I
E. coli Sakai genome. These sequences accounted for 503
(62.0%) of the contigs and were not analyzed further. The
remaining 308 contigs were reasoned to be enriched for se-
quences that are unique to lineage II strains. In order to de-
termine the distribution of these DNA sequences in our E. coli
O157:H7 collection of 44 strains of different LSPA-6 genotypes
(Table 1), PCR primers were designed to detect representative
target sequences from these contigs (Table 2). The 27 PCR
targets tested included 11 of the 16 sequences detected in all
three SSH experiments, 11 of the 73 sequences detected in two
SSH experiments, and five sequences detected in single SSH
experiments (Tables 3 and 4). Class B, C, E, and F sequences
represent insertions of DNA segments in lineage II strains with
respect to the lineage I E. coli Sakai genome, and class D
sequences represent deletions in lineage II strains with respect
to the position of the element in the E. coli Sakai genome. The
approximate location of these contigs and their corresponding
PCR targets in the E. coli O157:H7 genome are shown in
Fig. 1.
Distribution of lineage II SSH sequences among E. coli
O157:H7 strains. Class B loci possessed at least 80% sequence
identity over at least 50 bp to bacteriophage sequences not
found in E. coli O157:H7 lineage I strain Sakai (Table 4).
These sequences were present in 92 (11.3%) of the 811 contigs,
ranged in size from 66 to 3,180 bp, and represented 73,574 of
the 565,341 nucleotides (13.0%) from all of the contigs. The 16
primer sets from class B loci amplified DNA from the majority
of lineage II strains but not from any of the lineage I strains.
Some of these primer sets generated identical strain distribu-
tion patterns and were derived from contigs sharing homology
with different segments of a single prophage that may be
unique to lineage II strains. The class B target sequences share
identity with several genes of other lambdoid prophage, includ-
ing prophage from E. coli UTI89 (7), stx1-converting bacterio-
phage BP-4795 from E. coli O84:H4 4795/97 (8), cryptic pro-
phage e14 from E. coli K-12 (5), E. coli bacteriophage P2
(accession number AF063097), P4-like bacteriophage from E.
coli H709c (23), two different Shigella boydii Sb227 bacterio-
phages (45), and E. coli bacteriophage HK022 (19). It is well
known that bacteriophages are major contributors of genetic
diversity in E. coli O157 and other enteric bacteria (21, 22, 34,
39, 40). Further characterization of these lineage II conserved
bacteriophages will be required to determine their effect on the
phenotype of this group of E. coli O157:H7 strains.
Class C loci likely represent transitional sequences between
lineage-common and strain- or lineage-specific DNA. They
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consist of stretches of DNA sequence with at least 80% se-
quence identity over at least 50 bp to E. coli Sakai genes
adjacent to non-Sakai DNA sequences, and they were found in
8.9% (72/811) of the contigs, ranged in size from 277 to 2,232
bp, and represented 54,989 (9.7%) of all of the contig nucle-
otides. The two class C primer sets, A14 and A15, have one
primer in each set within sequences conserved among lineage
I and lineage II strains and the other member of the pair in
adjacent non-Sakai DNA. A14 targets a DNA segment within
the non-LEE effector (NLE)-encoding Sakai prophage (Sp) 6,
and A15 targets a DNA segment in Sp7. PCR products from
these primer sets amplified the same-size segments in nearly all
lineage II strains but did not produce a PCR product with
DNA from any of the lineage I strains. These novel segments
in lineage II strains are likely the result of insertion/deletion
events resulting in the loss of DNA (in lineage I) or acquisition
of DNA (in lineage II).
In contrast to class E loci, class D loci were missing chro-
mosomal DNA segments found in lineage I strain Sakai. These
sequences were found in 2.3% (19/811) of the contigs, ranged
FIG. 1. Approximate location of lineage II-specific regions with respect to the E. coli O157:H7 strain Sakai genome. Contigs containing lineage
II-specific regions together with regions with identity to the Sakai genome were used to place the lineage II-specific regions on the circular map,
using the CGView program (43). Red regions represent lineage II-specific loci which are centered at their approximate insertion points with respect
to the Sakai genome. Twenty-five of the 27 primers were placed on the Sakai genome in an analogous fashion. Two primer sets (B01 and B18)
could not be placed on the map because they targeted lineage II-specific contigs that were missing sequences with identity to the Sakai genome
to serve as reference points.
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in size from 438 to 1,427 bp, and represented 17,213 (3.0%) of
all contig nucleotides. Two of the class D primer sets, A06c and
A07, amplify sequences flanking the insertion sites of the Sakai
Stx2-encoding Sp5 and the NLE-encoding Sp10, respectively.
In contrast to all E. coli O157:H7 lineage I strains, most lineage
II strains produced amplicons with these primers, showing that
Sp5 and Sp10 are not present in the respective lineage I chro-
mosomal prophage insertion sites. This finding is supported by
other studies that have shown that the chromosomal location
of the stx2-transducing prophage Sp5 varies among E. coli
O157:H7 strains (35, 40). The third primer set was based on a
contig with identity to S-loop 83. In lineage II strains, the E.
coli Sakai open reading frame (ORF) ECs1688 is juxtaposed
next to ECs1705 due to an apparent insertion/deletion in the
intervening ORFs. This region encodes a putative iron trans-
port gene cluster with identity to the prrA-modD-yc73-fepC
region of the pyonephritis and cystitis pathogenicity island of
E. coli CFT073 (13). All three of the class D loci were also
identified in a previous study of lineage I-specific genomic
segments (42). In the latter study, a segment of DNA in the
tellurite resistance and adherence-conferring genomic island
carrying the perC-like regulatory protein gene, pchD, was also
found to be missing in lineage II strains. The fact that the genes
contained within these regions include stx2 in Sp5, a putative
iron transport gene cluster in S-loop 83, and a gene with sim-
ilarity to the perC-like LEE1 regulator in the tellurite resis-
tance and adherence-conferring genomic island provides
strong evidence of key differences in virulence-associated traits
between these two lineages.
Class E loci possessed at least 80% sequence identity over at
least 50 bp to nonbacteriophage DNA sequences found in
bacteria other than E. coli O157:H7 strain Sakai, ranged in size
from 51 to 3,110 bp, and represented 9.9% (80 of 811) of the
contigs or 54,989 (9.7%) of all contig nucleotides. Primer set
A01 amplified a target with identity to the E. coli strain EC93
cdiB gene (3). The cdiB gene is part of a cell contact-depen-
dent growth inhibition system in E. coli EC93 and uropatho-
genic E. coli strains, which has been shown to inhibit in vitro
growth of E. coli K-12 (3). While the cdiB gene was highly
prevalent among lineage II strains of LSPA-6 222222 (Table
4), lineage I strains were missing this operon. The lineage II
conserved region amplified by primer set B12 has identity to a
putative regulatory gene and two hypothetical genes found in
the uropathogenic E. coli strain UTI89 (7) and the avian
pathogenic E. coli serotype O1 strain (18). This sequence was
absent from lineage I strains but present in all lineage II strains
except for genotype LSPA-6 211111 strains.
The other two class E PCR primer sets, B05 and B18, rep-
resent colicin genes identified at high frequency within the E.
coli FRIK 920-E. coli Sakai SSH library but not in either of the
two remaining SSH experiments. These targets were not lin-
eage specific. The colicin E gene was amplified by the B05
primers and was found only in the strain FRIK 920, while the
colicin D gene targeted by primer set B18 was found among
both lineages but more commonly among genotype LSPA-6
222222 strains (8/17 or 47.1%) than lineage I genotype LSPA-6
111111 strains (5/17 or 29.4%) (Table 4).
Class F contigs had very little or no identity to sequences in
the GenBank NR database. These were 50 bp in length and
contained 80% sequence identity over any 50-bp stretch
within the contig or contained no region of 50 bp in length
with 80% sequence identity (criteria used for inclusion in
classes B, C, and E). Class F represented 23.2% (188/811) of
the contigs, ranged in size from 51 bp to 3,485 bp, and included
150,034 (26.5%) of all contig nucleotides. PCR analysis with
the A12 and B13 primer sets confirmed that these segments are
present in a large number of lineage II strains and are there-
fore not due to artifacts of the SSH methodology. Although the
function of these genes is unknown, the fact that they are
conserved in lineage II strains, coupled with their prevalence
within the SSH libraries (23.3%), would argue that they play an
important functional role in the survival of the organism.
PCR amplicons generated from tester strains were se-
quenced and compared with the original contigs to confirm
correct assembly of the SSH sequences. The sequences ob-
tained were 89 to 100% identical to the original contigs, sug-
gesting that the original assemblies were correct and represen-
tative of the actual genomic sequences. The high proportion of
primer sets (25/27) that amplified these sequences in the E. coli
O157:H7 lineage II strains tested illustrates that SSH is a
robust method for isolating strain-specific sequences.
Genotyping of E. coli O157:H7 strains based on lineage II
conserved loci. Sequences identified in this study suggest that
genomic content and organization vary within lineage I and
lineage II populations. Even within a lineage, diversity can be
observed, as few loci are conserved in every isolate tested
within a lineage. Nonetheless, when heritability of the SSH
markers is examined as a whole, the extent of genomic diversity
distinguishing the two lineages is impressive. As illustrated in
Fig. 2, neighbor-joining analysis of the PCR data (converted to
binary strings) shows that the major LSPA-6 genotypes behave
as a group with respect to genomic diversity. With the excep-
tion of a single LSPA-6 111111 strain, human phage type 14
strain ECI-485, E. coli O157:H7 strains from lineage I (LSPA-6
111111) and from lineage II (other LSPA-6 genotypes) clus-
tered separately (ECI-485 clustered with the lineage II strains,
not with the other lineage I strains). While the LSPA-6 mark-
ers are within backbone regions of the genome, many of the
lineage-specific loci found in this study are located within mo-
bile genetic elements such as phage; this congruence implies
that selection is uniquely shaping the genomes of these two
lineages.
Within lineage II, the LSPA-6 genotype 211111 strains
showed significant strain-strain diversity (Fig. 2). We have pre-
viously shown that LSPA-6 genotype 211111 strains group sep-
arately from other E. coli O157:H7 strains and share genomic
characteristics of lineage I or lineage II populations at inde-
pendent loci (42), leading us to categorize them as lineage I/II
strains. This finding, coupled with the fact that the lineage II
SSH markers are not uniformly distributed within LSPA-6
genotype 211111, suggests that there is significant diversity
among lineage I/II strains and that they are distinct from lin-
eage I and lineage II strains (47).
Statistical analysis of the distribution of lineage I and lineage
II strains has previously shown biases in the frequency with
which some subtypes are found in bovine or human clinical
samples (46). In this report and our previous studies, we have
identified genomic features that differentiate populations of
these lineages. As observed in other studies, bacteriophages
are important contributors to genomic diversity in this organ-
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ism. Whether these phages carry unique combinations of vir-
ulence genes and regulatory genes or otherwise influence phys-
iological traits of the two lineages remains to be determined.
A large number of studies now have confirmed that genomic
alterations associated with bacteriophage differentiate sub-
populations of E. coli O157:H7 (34, 39, 40). Unfortunately,
many of these studies have not been done within a phyloge-
netic context, so it is difficult to determine how those results
relate to lineage I and II groupings. Nonetheless, collectively,
the studies show that the phage-mediated events are common
and that they are also the common events discriminating the
two lineages. Since both lineages coexist temporally and spa-
tially, we would expect that they would be exposed to similar
phage pools in nature. However, it would appear that these
lineages have different host distributions and that they may
have different selective pressures or differ in the strategies used
to deal with these selective forces. It is also possible that they
are uniquely susceptible to lysogeny by certain bacteriophages.
FIG. 2. Phylogenetic relatedness of E. coli O157:H7 strains based on the presence of 18 lineage II conserved molecular markers. A neighbor-
joining dendrogram was generated based on a matrix of pairwise distances calculated from the binary data by using the proportion of shared lineage
II markers as a distance metric. Marker distribution is shown on the right, with positive PCR results indicated by black boxes and negative results
indicated by white boxes. The level of support as a proportion of 500 bootstrap replicates is indicated on each branch on the dendrogram.
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Recently we have shown phage type to be lineage-related in E.
coli O157:H7 strains (48). The mode of acquisition of these
phage-related elements and their effect on phenotype are at
present unknown but will become clearer as these lineage-
specific loci begin to be studied.
A number of the differentially distributed elements have the
potential to affect the ecology and pathogenicity of E. coli
O157:H7. Within lineage I strains, these include genomic re-
gions containing the stx2-transducing Sakai prophage Sp5 and
a putative iron transport gene cluster with homology to the
prrA-modD-yc73-fepC gene cluster of E. coli CFT073 (13).
Within lineage II strains, these include genes for a putative
contact-dependent inhibition system (3) and a putative regu-
latory gene found within the uropathogenic E. coli strain
UTI89. In addition, this study identified the existence of other
bacteriophage-related elements that appear to be conserved
among lineage II E. coli O157:H7 strains. These may possess
factors which influence the virulence and host distribution of
E. coli O157:H7 lineages.
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